Form 4 for CVS CVS Health
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0001127602-25-014954 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-19 | 2025-05-15 | CVS | Finucane Anne A. | Dir | A - Grant | $60.47 | +692 | 692 | New | +$41.8K |
| D | 2025-05-19 | 2025-05-15 | CVS | Finucane Anne A. | Dir | A - Grant | $60.47 | +2,077 | 14.5K | +17% | +$125.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | A | A | 692 | $60.47 | 692 | D | — | — | |
| 2 | Derivative | Deferred Stock Units | 2025-05-15 | A | A | 2,077.48 | $60.47 | 14,513.27 | D | $0.00 · — to — | 2,077.48 Common Stock | (F3) Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person. |